<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prevalence of chemotherapy-related <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> is increasing and management demands a multidisciplinary approach from cardiologists and oncologists </plain></SENT>
<SENT sid="1" pm="."><plain>Pretreatment identification of predisposing risk factors and assessment of cardiac function before and at intervals during and after therapy with <z:chebi fb="0" ids="50912">cardiotoxic agents</z:chebi> are necessary </plain></SENT>
<SENT sid="2" pm="."><plain>In clinical practice, surveillance is largely performed using transthoracic echocardiography or multi-gated radionuclide angiography </plain></SENT>
<SENT sid="3" pm="."><plain>Imaging strategies that detect cardiac injury before overt left ventricular systolic dysfunction provide an opportunity for early intervention and improved cardiac outcomes </plain></SENT>
</text></document>